“…The structures of noncovalent SCRs include calixarenes and oligoaromatic receptors, ,− cyclodextrins, ,− porphyrin conjugates, podand receptors, ,,,,,,,,,,− peptide-based receptors, , cholaphanes, and the encapsulating temple receptors. ,,,,,,,,,− Although several reviews of noncovalent SCRs exist, − ,, the field continues to develop rapidly and a few key examples are highlighted below to discuss the design of noncovalent SCRs (Figure ) and their evolution as antivirals.…”